[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES521371A0 - Un procedimiento para la purificacion de un anticuerpo. - Google Patents

Un procedimiento para la purificacion de un anticuerpo.

Info

Publication number
ES521371A0
ES521371A0 ES521371A ES521371A ES521371A0 ES 521371 A0 ES521371 A0 ES 521371A0 ES 521371 A ES521371 A ES 521371A ES 521371 A ES521371 A ES 521371A ES 521371 A0 ES521371 A0 ES 521371A0
Authority
ES
Spain
Prior art keywords
antibody
purification
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521371A
Other languages
English (en)
Other versions
ES8404858A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of ES8404858A1 publication Critical patent/ES8404858A1/es
Publication of ES521371A0 publication Critical patent/ES521371A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES521371A 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo. Granted ES521371A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12

Publications (2)

Publication Number Publication Date
ES8404858A1 ES8404858A1 (es) 1984-05-16
ES521371A0 true ES521371A0 (es) 1984-05-16

Family

ID=23448565

Family Applications (3)

Application Number Title Priority Date Filing Date
ES521371A Granted ES521371A0 (es) 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo.
ES528000A Granted ES528000A0 (es) 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno.
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES528000A Granted ES528000A0 (es) 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno.
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.

Country Status (11)

Country Link
EP (1) EP0105359A4 (es)
AT (1) AT393386B (es)
AU (1) AU622099B2 (es)
CA (1) CA1209907A (es)
CH (1) CH672028A5 (es)
DK (1) DK192191A (es)
ES (3) ES521371A0 (es)
FI (1) FI88403C (es)
GB (1) GB2128630B (es)
IT (1) IT1219779B (es)
WO (1) WO1983003678A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (sv) * 1987-03-06 1993-02-22 Perstorp Biolytica Adsorbent foer isokratisk affinitetskromatografi
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
JPH03500682A (ja) * 1987-07-14 1991-02-14 ザ　ビクトリア　ユニヴアーシテイ　オブ　マンチエスター 診断方法
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
JP2001502895A (ja) * 1996-09-20 2001-03-06 ザ・ジェネラル・ホスピタル・コーポレイション アルファ―２―抗プラスミンに対するキメラ、ヒト化および一本鎖抗体
KR102051275B1 (ko) * 2008-04-11 2019-12-04 추가이 세이야쿠 가부시키가이샤 복수 분자의 항원에 반복 결합하는 항원 결합 분자
TWI812066B (zh) 2010-11-30 2023-08-11 日商中外製藥股份有限公司 具有鈣依存性的抗原結合能力之抗體
US20140093496A1 (en) 2011-02-25 2014-04-03 Chugai Seiyaku Kabushiki Kaisha Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
BR112014013081A2 (pt) 2011-11-30 2020-10-20 Chugai Seiyaku Kabushiki Kaisha veículo contendo fármaco em célula para formação de um complexo imune
TWI779010B (zh) 2014-12-19 2022-10-01 日商中外製藥股份有限公司 抗肌抑素之抗體、含變異Ｆｃ區域之多胜肽及使用方法
KR101838645B1 (ko) 2014-12-19 2018-03-14 추가이 세이야쿠 가부시키가이샤 항-c5 항체 및 그의 사용 방법
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
KR102538749B1 (ko) 2016-08-05 2023-06-01 추가이 세이야쿠 가부시키가이샤 Il-8 관련 질환의 치료용 또는 예방용 조성물
US11608374B2 (en) 2017-01-30 2023-03-21 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
CN110724204B (zh) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Fc融合蛋白的纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
EP0059598B1 (en) * 1981-02-26 1985-07-17 Unilever Plc A process and apparatus for the recovery of immunoglobulines
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
EP0105359A4 (en) 1984-08-20
CA1209907A (en) 1986-08-19
FI88403C (fi) 1993-05-10
ES8706964A1 (es) 1987-07-01
ATA901983A (de) 1991-03-15
AU622099B2 (en) 1992-04-02
GB2128630B (en) 1986-08-28
WO1983003678A1 (en) 1983-10-27
IT1219779B (it) 1990-05-24
FI834530A0 (fi) 1983-12-09
FI88403B (fi) 1993-01-29
ES8404858A1 (es) 1984-05-16
IT8320550A0 (it) 1983-04-12
GB8332644D0 (en) 1984-01-11
GB2128630A (en) 1984-05-02
ES8506902A1 (es) 1985-08-01
FI834530A (fi) 1983-12-09
DK192191D0 (da) 1991-11-26
ES528001A0 (es) 1987-07-01
CH672028A5 (es) 1989-10-13
ES528000A0 (es) 1985-08-01
DK192191A (da) 1991-11-26
EP0105359A1 (en) 1984-04-18
AU7256987A (en) 1987-09-03
AT393386B (de) 1991-10-10

Similar Documents

Publication Publication Date Title
ES521371A0 (es) Un procedimiento para la purificacion de un anticuerpo.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES523858A0 (es) Un procedimiento para la preparacion de benzotienil benzofuranil o naftil-derivados.
ES525175A0 (es) Procedimiento para la formacion de un compuesto elastico.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES507506A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES515159A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES521984A0 (es) Un procedimiento para la produccion de ribavirina.
ES524346A0 (es) Procedimiento para la obtencion de poliaminas primarias.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES507919A0 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
ES523136A0 (es) Un procedimiento para la preparacion de un compuesto.
ES514335A0 (es) Un procedimiento para la preparacion de guanidinas.
ES499936A0 (es) Un procedimiento para la purificacion de glucosaminoglucanos
ES506034A0 (es) Un procedimiento para la preparacion de n-carboxialquil-dipeptidos.
ES532777A0 (es) Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas.
ES520076A0 (es) Un procedimiento para la preparacion de pirropirroles.
ES520140A0 (es) Un procedimiento para la preparacion de acicloguanosina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401